Glenn Goddard has nearly two decades of experience leading business and financial operations for public and private companies in the biotechnology industry. Prior to joining Intellia, Glenn served as the Chief Financial Officer at Generation Bio Company, where he led all financial functions, investor relations, information technologies and certain operational functions. During his time at Generation Bio, he closed a $100 million private financing and a long-term lease deal for 75,000 square feet of lab and office space. Before joining Generation Bio, Glenn served as Senior Vice President of Finance and Principal Financial Officer of Agios Pharmaceuticals, where he led the company’s strategic financings efforts raising more than $700 million in equity financings, including a private crossover financing, an initial public offering and several subsequent follow-on offerings. In addition, Glenn was responsible for all financial functions of the company, including strategic planning and analysis, investor relations, treasury, tax, finance and accounting. He also was responsible for information technologies, certain operational functions and supporting strategic partnering efforts.
Previously, Glenn held various senior-level financial management positions at both Archemix, a privately held oligonucleotide platform-based biopharmaceutical company, and Immunogen, a publicly traded oncology-focused biopharmaceutical company. Earlier in his career, Glenn was an audit supervisor at Ernst & Young LLP and a business advisory manager at Feeley & Driscoll, P.C. Glenn is a graduate of Bentley College, where he earned a B.S. in Accountancy and is a Certified Public Accountant in the Commonwealth of Massachusetts.
What is Glenn Goddard's net worth?
The estimated net worth of Glenn Goddard is at least $556,420.35 as of January 3rd, 2024. Mr. Goddard owns 40,585 shares of Intellia Therapeutics stock worth more than $556,420 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Goddard may own. Additionally, Mr. Goddard receives an annual salary of $630,910.00 as CFO at Intellia Therapeutics. Learn More about Glenn Goddard's net worth.
How old is Glenn Goddard?
Mr. Goddard is currently 53 years old. There are 8 older executives and no younger executives at Intellia Therapeutics. The oldest executive at Intellia Therapeutics is Dr. David Lebwohl M.D., Executive VP & Chief Medical Officer, who is 69 years old. Learn More on Glenn Goddard's age.
What is Glenn Goddard's salary?
As the CFO of Intellia Therapeutics, Inc., Mr. Goddard earns $630,910.00 per year. There are 5 executives that earn more than Mr. Goddard. The highest earning executive at Intellia Therapeutics is Mr. Nessan Bermingham Ph.D., Founder & Member of Scientific Advisor Board, who commands a salary of $1,380,000.00 per year. Learn More on Glenn Goddard's salary.
How do I contact Glenn Goddard?
Has Glenn Goddard been buying or selling shares of Intellia Therapeutics?
Glenn Goddard has not been actively trading shares of Intellia Therapeutics in the last ninety days. Most recently, Glenn Goddard sold 5,365 shares of the business's stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $29.46, for a transaction totalling $158,052.90. Following the completion of the sale, the chief financial officer now directly owns 40,585 shares of the company's stock, valued at $1,195,634.10. Learn More on Glenn Goddard's trading history.
Who are Intellia Therapeutics' active insiders?
Are insiders buying or selling shares of Intellia Therapeutics?
In the last year, insiders at the sold shares 7 times. They sold a total of 37,420 shares worth more than $1,085,489.31. The most recent insider tranaction occured on October, 2nd when CAO Michael P Dube sold 2,012 shares worth more than $38,248.12. Insiders at Intellia Therapeutics own 3.2% of the company.
Learn More about insider trades at Intellia Therapeutics. Information on this page was last updated on 10/2/2024.
